Subscribe Us

header ads

Recents

header ads

Dental Biomaterials Market Size, Growth, Demands Outlook and Forecasts to 2030

Precedence Research - February 01, 2023

According to the research report, the global dental biomaterials market size is expected to touch USD 13.6 Billion by 2030, from USD 8.45 Billion in 2022, growing with a significant CAGR of 6.8% from 2022 to 2030. 

Dental Biomaterials Market Size | Statistics 2021 to 2030

The dental biomaterials report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global dental biomaterials in conjunction with the geographical landscape of this vertical have also been included in this report.

The report offers intricate dynamics about different aspects of the global dental biomaterials market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global dental biomaterials during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link @ https://www.precedenceresearch.com/sample/1684

 Report Scope of the Dental Biomaterials Market

Report CoverageDetails
Market Size by 2030USD 13.6 Billion
Growth Rate from 2022 to 2030

CAGR of 6.8%

North America Market Share in 202238%
Dental Laboratories Segment Market Share in 202239%
Base Year2022
Forecast Period2023 to 2030
Segments CoveredType, Application, End Use, Bone Graft Material Type, Geography

This study covers a detailed segmentation of the global dental biomaterials market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global dental biomaterials market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.

Key Players

  • 3M Company
  • Bego Medical GmbH
  • Carpenter Technology Corporation
  • Danaher Corporation
  • Datum Dental Ltd.
  • GC Corporation
  • Henry Schein Inc.
  • IvoclarVivadent AG
  • Keystone Dental Inc.
  • Medtronic PLC

Market Segmentation

 By Type

  • Metallic Biomaterials
    • Titanium
    • Stainless Steel
    • Chromium Alloys
    • Other Metallic
  • Ceramic Biomaterials
  • Polymeric Biomaterials
  • Metal-Ceramic Biomaterials
  • Natural Biomaterials
  • Composites Biomaterials

By Application

  • Implantology
  • Orthodontics
  • Prosthodontics
  • Others

By End Use

  • Dental Hospitals and Clinics
  • Dental Laboratories
  • Dental Academics and Research Institutes
  • Dental Product Manufacturers

By Bone Graft Material Type

  • Allograft
  • Xenograft
  • Synthetic

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Research Methodology

The research methodology adopted by analysts for compiling the global dental biomaterials report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global dental biomaterials market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Dental Biomaterials Market 

5.1. COVID-19 Landscape: Dental Biomaterials Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Dental Biomaterials Market, By Type

8.1. Dental Biomaterials Market, by Type, 2022-2030

8.1.1. Metallic Biomaterials

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Ceramic Biomaterials

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Polymeric Biomaterials

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Metal-Ceramic Biomaterials

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Natural Biomaterials

8.1.5.1. Market Revenue and Forecast (2017-2030)

8.1.6. Composites Biomaterials

8.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Dental Biomaterials Market, By Application

9.1. Dental Biomaterials Market, by Application, 2022-2030

9.1.1. Implantology

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Orthodontics

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Prosthodontics

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Others

9.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Dental Biomaterials Market, By End Use Type 

10.1. Dental Biomaterials Market, by End Use Type, 2022-2030

10.1.1. Dental Hospitals and Clinics

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Dental Laboratories

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Dental Academics and Research Institutes

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Dental Product Manufacturers

10.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Dental Biomaterials Market, By Bone Graft Material Type

11.1. Dental Biomaterials Market, by Bone Graft Material Type, 2022-2030

11.1.1. Allograft

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Xenograft

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Synthetic

11.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Dental Biomaterials Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Type (2017-2030)

12.1.2. Market Revenue and Forecast, by Application (2017-2030)

12.1.3. Market Revenue and Forecast, by End Use Type (2017-2030)

12.1.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Type (2017-2030)

12.1.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.1.5.3. Market Revenue and Forecast, by End Use Type (2017-2030)

12.1.5.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Type (2017-2030)

12.1.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.1.6.3. Market Revenue and Forecast, by End Use Type (2017-2030)

12.1.6.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Type (2017-2030)

12.2.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.3. Market Revenue and Forecast, by End Use Type (2017-2030)

12.2.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Type (2017-2030)

12.2.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.5.3. Market Revenue and Forecast, by End Use Type (2017-2030)

12.2.5.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Type (2017-2030)

12.2.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.6.3. Market Revenue and Forecast, by End Use Type (2017-2030)

12.2.6.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Type (2017-2030)

12.2.7.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.7.3. Market Revenue and Forecast, by End Use Type (2017-2030)

12.2.7.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Type (2017-2030)

12.2.8.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.8.3. Market Revenue and Forecast, by End Use Type (2017-2030)

12.2.8.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Type (2017-2030)

12.3.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.3. Market Revenue and Forecast, by End Use Type (2017-2030)

12.3.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Type (2017-2030)

12.3.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.5.3. Market Revenue and Forecast, by End Use Type (2017-2030)

12.3.5.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Type (2017-2030)

12.3.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.6.3. Market Revenue and Forecast, by End Use Type (2017-2030)

12.3.6.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Type (2017-2030)

12.3.7.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.7.3. Market Revenue and Forecast, by End Use Type (2017-2030)

12.3.7.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Type (2017-2030)

12.3.8.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.8.3. Market Revenue and Forecast, by End Use Type (2017-2030)

12.3.8.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Type (2017-2030)

12.4.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.3. Market Revenue and Forecast, by End Use Type (2017-2030)

12.4.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Type (2017-2030)

12.4.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.5.3. Market Revenue and Forecast, by End Use Type (2017-2030)

12.4.5.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Type (2017-2030)

12.4.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.6.3. Market Revenue and Forecast, by End Use Type (2017-2030)

12.4.6.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Type (2017-2030)

12.4.7.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.7.3. Market Revenue and Forecast, by End Use Type (2017-2030)

12.4.7.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Type (2017-2030)

12.4.8.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.8.3. Market Revenue and Forecast, by End Use Type (2017-2030)

12.4.8.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Type (2017-2030)

12.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.5.3. Market Revenue and Forecast, by End Use Type (2017-2030)

12.5.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Type (2017-2030)

12.5.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.5.5.3. Market Revenue and Forecast, by End Use Type (2017-2030)

12.5.5.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Type (2017-2030)

12.5.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.5.6.3. Market Revenue and Forecast, by End Use Type (2017-2030)

12.5.6.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)

Chapter 13. Company Profiles

13.1. 3M Company

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Bego Medical GmbH

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Carpenter Technology Corporation

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Danaher Corporation

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Datum Dental Ltd.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. GC Corporation

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Henry Schein Inc.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. IvoclarVivadent AG

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Keystone Dental Inc.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Medtronic PLC

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com

 

Tags:

Post a Comment

0 Comments